# Randomized Trial of First-Line Tyrosine Kinase Inhibitor With or Without Radiotherapy for Synchronous Oligometastatic <i>EGFR</i>-Mutated Non-Small Cell Lung Cancer

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/randomized-trial-of-first-line-tyrosine-kinase-inhibitor-with-or-without/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Xiaoshan Wang,Yifeng Bai,Vivek Verma,Ruilian Yu,Wei Tian,Rui Ao,Ying Deng,Xue-Qiang Zhu,Hao Liu,Haixia Pan,Lan Yang,Hansong Bai,Xing Luo,Yan Guo,Mingxiu Zhou,Yuemei Sun,Zi-Can Zhang,Simin Li,Xue Cheng,Bangxian Tan,Liang-Fu Han,Yingyi Liu,Kai Zhang,Fanxin Zeng,Lin Jia,Xinbao Hao,You‐Yu Wang,Gang Feng,Ke Xie,You Lü,Ming Zeng |
| Citations | 266 |
| DOI | 10.1093/jnci/djac015 |
| Fields | Medicine |
| Open Access | true |
| OA Status | hybrid |
| OA URL | https://academic.oup.com/jnci/advance-article-pdf/doi/10.1093/jnci/djac015/42619892/djac015.pdf |
| OpenAlex ID | https://openalex.org/W4210289312 |
| PMID | 35094066 |
| Type | article |
| Year | 2022 |

## Paper authors

- [Hao Liu](https://scholariq.org/researchers/hao-liu/)
- [You Lü](https://scholariq.org/researchers/you-lu/)
- [Ming Zeng](https://scholariq.org/researchers/ming-zeng/)

## Paper journal

- [JNCI Journal of the National Cancer Institute](https://scholariq.org/journals/jnci-journal-of-the-national-cancer-institute/)

## Paper primary topic

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)

## Paper topics

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Lung Cancer Diagnosis and Treatment](https://scholariq.org/topics/lung-cancer-diagnosis-and-treatment/)
- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.